Dr Liz Dallimore
Argenica Therapeutics (ASX:AGN)

Dr Liz Dallimore

Managing Director
Argenica Therapeutics (ASX:AGN)

In this episode, we sit down with Dr Liz Dallimore, the Chief Executive Officer and Managing Director of Argenica Therapeutics, to delve into the most recent updates and valuable insights from AGN. Additionally, we take a closer look at the inner workings that drive Liz’s passion and expertise.

Dr Liz Dallimore is a research & development, innovation and commercialisation specialist with over 20 years’ experience across Australia and the UK. Prior to joining Argenica Therapeutics, Dr Dallimore was the Director of the WA Data Science Innovation Hub, tasked with working across WA businesses to establish innovative data science projects. Dr Dallimore has also held senior roles in management consulting across Australia, most recently as KPMG’s National Director of Research Engagement and Commercialisation. Prior to this she held senior roles with Ernst & Young and PricewaterhouseCoopers. Dr Dallimore is a co-founder of medical device company Inspiring Holdings, sits on the AusBiotech WA Committee and is a non-executive Director of NERA, a Federal Government Growth Centre. Dr Dallimore has a PhD in Neuroscience jointly completed at Oxford University and the University of Western Australia and has worked as a neuroscientist at the Australian Neuromuscular Research Institute (now Perron Institute). In 2020, Dr Dallimore was recognised as one of Western Australia’s Top Women in Tech.